Assessment of a Key Message in Newly Diagnosed Type 2 Diabetes Mellitus Patients Considering Their Educational ProgramCiprian Constantin1* and Aurelian Ranetti2
- *Corresponding Author:
- Ciprian Constantin
Carol Davila Central Military Hospital
Diabetes Department 001085 Bucharest 1
88 Mircea Vulcanescu Street, Romania
E-mail: [email protected]
Received date: January 01, 2016; Accepted date: January 29, 2016; Published date: February 03, 2016
Citation: Constantin C, Ranetti A (2016) Assessment of a Key Message in Newly Diagnosed Type 2 Diabetes Mellitus Patients Considering Their Educational Program. J Nutr Disorders Ther 6:182. doi:10.4172/2161- 0509.1000182
Copyright: © 2016 Constantin C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: It is well known that therapeutic nutrition education provided to patients with new diagnosed type 2 diabetes mellitus is crucial in terms of subsequent adherence to a dedicated multi-factorial treatment. The patient could be empowered to act on insulin dose and/or on other aspects (calorie intake, therapeutically efforts and sleep schedule etc.) regarding the achievement of the final therapeutic targets.
Objective: The aim of this retrospective study was to determine the impact of the message perceived by patients with new diagnosed type 2 diabetes mellitus on the means used in achieving metabolic control at 3 months of treatment after an initial educational program.
Method: We performed a retrospective, case-control study of 143 patients with new diagnosed type 2 diabetes mellitus patients admitted to general hospital wards to investigate the relationship between remaining messages after attending our educational program with all methods to achieve adequate metabolic control. It was hypothesized that message have a great impact considering all methods to achieve this targets and are associated with a greater impact of dose insulin.
Result: At the moment of evaluation we find that the dose of insulin is significantly different between the two lots: 0.43 ± 0.02 UI/Kgc vs. 0.13 ± 0.01 UI/Kgc, p <0.05; and the level of physical therapeutic effort is also significantly different 2.12 ± 0.35 MET/day vs. 3.51 ± 0.32 MET/day, p<0.05. At the same time weight loss, as well as HbA1c levels that the groups reached, have statistical significance (p<0.05).
Conclusion: We could say at the final of our study that the main message of our program is associated with a lower dose of insulin used for treatment of type 2 diabetes mellitus patients.